Jump to content

COVID vaccines in IgA deficiency?


Alfred001
 Share

Recommended Posts

What does the evidence say (if there is any) on a) the safety and b) the efficacy of COVID vaccines in people with IgA deficiency? I assume both a and b may differ depending on whether it's an mRNA or old technology vaccine.

Link to comment
Share on other sites

I don't know whether there are larger studies with immunocompromised patient cohorts, but small-scale studies show that the vaccines were well tolerated, but immunogenicity varied quite a bit. While some of the patients might have selective IgA deficiency, I don't know whether there are studies focusing on this conditions specifically. Generally speaking though, they would expected to have similar or better outcomes than compared to other immunocompromised patients.

See e.g. Ponsford, M.J., Evans, K., Carne, E.M. et al. COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort. J Clin Immunol 42, 728–731 (2022). https://doi.org/10.1007/s10875-022-01223-7

Some other studies seem to show some level of protection, but it looks a bit different than in non-immunocompromised individuals and breakthrough infections (pre-Omicron) were a bit more common.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
 Share

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.